The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBrown Group Regulatory News (BWNG)

Share Price Information for Brown Group (BWNG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 14.20
Bid: 14.20
Ask: 16.00
Change: 0.70 (4.86%)
Spread: 1.80 (12.676%)
Open: 14.20
High: 14.20
Low: 14.20
Prev. Close: 14.40
BWNG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update

23 Mar 2020 07:00

RNS Number : 1193H
Brown (N.) Group PLC
23 March 2020
 

Trading update

 

In light of current market conditions and the rapidly changing developments regarding Covid-19, N Brown plc (the "Group" or the "Company") provides the following update.

 

Our absolute priority has been to ensure the wellbeing of our colleagues, both in Head Office and across our distribution centres, whilst continuing to deliver the service and functionality for our customers to continue shopping our brands. Our colleagues and our supplier partners have been excellent in adapting to a more flexible way of working during this difficult period and remain as committed as ever to supporting our loyal customer base.

 

Demand

At this stage, there is no way of predicting the impact the virus will have on our sales, nor how long the pandemic will last and what effect it will have on customer behaviour. Trading for the first two weeks of the new financial year was in line with expectations. However, during the last week we have seen a very significant and sudden reduction in customer demand with daily product sales down in excess of 40% compared to expectations. Whilst it is impossible to give accurate guidance, we are anticipating a material reduction in demand through FY21.

 

As a result, the Company has taken a number of immediate and proactive measures to reduce costs and preserve liquidity, including:

· A significant reduction in marketing expenditure with immediate effect and for the foreseeable future if market conditions do not improve;

· Stopping and deferring all non-essential capital expenditure. This will have little or no impact on the short-term performance of the business;

· Working collaboratively with HMRC to secure the deferral of all tax and national insurance payments;

· Stopping stock purchases immediately, thereby aligning stock levels for SS20 with reduced customer demand. Going forward, we will be re-evaluating our stock intake plans; and

· Freezing all recruitment and reviewing organisational structures.

 

Our objective in relation to all of these actions is to preserve liquidity in the business and allow us to manage the business effectively and prudently through this highly uncertain period. In addition, the Group is exploring all options in relation to the Government and Bank of England support packages for business.

 

Liquidity

The Group has financing facilities in place totalling £652.5m, comprising:

· A securitisation facility secured by a charge over certain eligible customer receivables which is without recourse to any of the Group's other assets, and which is committed to December 2021. The facility is £500m but the amount that can be drawn under the facility is lower than this and depends on the level of eligible customer receivables at any one point in time;

· A Revolving Credit Facility ("RCF") of £125m which is committed to September 2021; and

· An overdraft of £27.5m.

 

As at 20 March 2020 the Group was drawn on the securitisation facility, to the maximum extent possible, being £414.7m and fully drawn down on the RCF of £125.0m. It had also drawn down £9.0m on the overdraft and held cash balances of £46.3m.

 

Whilst the Group is currently in compliance with its existing banking covenants, the downside scenario modelling we have conducted for Covid-19, involving a significant and sustained reduction in customer demand, indicates the need for amendments to existing banking covenants, changes in the way our securitisation facility operates and potentially additional facilities. The Group is progressing proactive, collaborative discussions with its long-standing, supportive lenders and is exploring options in relation to maximising the value of its significant unlevered debtor book. In addition, the Group is also exploring options in relation to its unencumbered freehold properties with an original cost of £58.3m.

 

Dividend

As a result of the initial impact of Covid-19 the Board will not be recommending a final dividend for the financial year ended 29 February 2020 and will suspend dividend payments for the foreseeable future.

 

FY20 guidance

The Bank of England in its 'Statement on IFRS 9 and Covid-19' on 20 March recognised that there is currently a very high level of uncertainty around how Covid-19 will impact the economy. It is, therefore, extremely difficult to quantify the expected impact as reliable and detailed forecasts cannot yet be made.

 

The Group is currently reviewing the potential impact of Covid-19 on its FY20 IFRS9 bad debt provision in light of significantly worse future macro-economic scenarios which impact the provision model.

Whilst the Board cannot be certain of the impact of Covid-19 on the Groups FY20 IFRS 9 Bad debt provision, the Board expects the Group's adjusted profit before tax to be lower than the previously guided range of £70m to £72m.

 

The Board had expected to release its Full Year Results for the year ended 29 February 2020 on 29 April 2020. However, due to working restrictions affecting both the Company and the Auditors, there is likely to be a delay to the publication of the results. A further announcement will be made in due course.

 

FY21 guidance

Given the current acute uncertainty, the Board does not believe it appropriate to provide financial guidance for the financial year ending 27 February 2021. Whilst Covid-19 will have a very significant impact on the Group's business, the Board remains confident in N Brown's proposition and the markets it serves.

 

This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014.

 

For further information:

 

N Brown Group

 

Will MacLaren, Director of Investor Relations and Corporate Communications

07557 014 657

 

 

MHP Communications

 

Andrew Jaques / Simon Hockridge / Ollie Hoare

07709 496 125 / 07824 142 725

NBrown@mhpc.com

 

About N Brown Group:

N Brown is a top 10 UK clothing & footwear digital retailer. We are size inclusive, focusing on the needs of underserved customer groups - size 20+ and age 50+. We offer an extensive range of products, predominantly clothing, footwear and homewares, and our financial services proposition allows customers to spread the cost of shopping with us. We are headquartered in Manchester where we design, source and create our product offer and we employ over 2,400 people across the UK.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTFFFLIVEIFFII
Date   Source Headline
18th Jan 20247:00 amRNSTrading Statement
16th Oct 202311:03 amRNSDirector/PDMR Shareholding
12th Oct 20237:00 amRNSInterim Results
7th Sep 202312:13 pmRNSN Brown announces partnership with Sainsbury’s
16th Aug 20231:59 pmRNSHolding(s) in Company
15th Aug 20232:02 pmRNSHolding(s) in Company
7th Aug 20233:30 pmRNSGrant of Nil Cost Options
2nd Aug 20237:00 amRNSIssue of equity and total voting rights
26th Jul 20231:09 pmRNSHolding(s) in Company
11th Jul 202311:59 amRNSHolding(s) in Company
10th Jul 20235:12 pmRNSResults of AGM and Confirmation of Board Changes
21st Jun 20234:49 pmRNSDirector/PDMR Shareholding
15th Jun 20237:00 amRNSTrading Statement
15th Jun 20237:00 amRNSAnnual Report and Accounts and Notice of AGM
13th Jun 20239:43 amRNSDirector/PDMR Shareholding
7th Jun 20237:00 amRNSConfirmation of CFO change and Board appointment
6th Jun 20237:00 amRNSFinal Results
22nd May 20237:00 amRNSNotice of Results
24th Apr 20238:32 amRNSHolding(s) in Company
5th Apr 20237:00 amRNSDirectorate Change
29th Mar 20234:35 pmRNSPrice Monitoring Extension
27th Mar 20234:35 pmRNSPrice Monitoring Extension
24th Feb 20234:35 pmRNSPrice Monitoring Extension
23rd Feb 20237:00 amRNSDominic Appleton appointed CFO Designate
8th Feb 20234:11 pmRNSHolding(s) in Company
7th Feb 20231:14 pmRNSDirectorate Change
7th Feb 202311:44 amRNSDirector/PDMR Shareholding
7th Feb 202311:41 amRNSDirector/PDMR Shareholding
3rd Feb 20235:19 pmRNSDirector/PDMR Shareholding
3rd Feb 20237:00 amRNSDirector/PDMR Shareholding
31st Jan 202312:28 pmRNSHolding(s) in Company
31st Jan 202311:06 amRNSDirector/PDMR Shareholding
30th Jan 20232:55 pmRNSHolding(s) in Company
27th Jan 20235:09 pmRNSHolding(s) in Company
27th Jan 20237:00 amRNSDirectorate Change
23rd Jan 20233:10 pmRNSHolding(s) in Company
23rd Jan 20233:06 pmRNSDirector/PDMR Shareholding
20th Jan 20235:37 pmRNSDirector/PDMR Shareholding
19th Jan 20234:42 pmRNSHolding(s) in Company
19th Jan 20234:38 pmRNSDirector/PDMR Shareholding
18th Jan 20234:01 pmRNSDirector/PDMR Shareholding
18th Jan 20233:57 pmRNSDirector/PDMR Shareholding
17th Jan 20238:14 amRNSDirector/PDMR Shareholding
16th Jan 20233:30 pmRNSDirector/PDMR Shareholding
16th Jan 20237:00 amRNSHolding(s) in Company
12th Jan 20234:35 pmRNSPrice Monitoring Extension
12th Jan 20237:00 amRNSTrading Statement
9th Jan 20237:00 amRNSSettlement of a Legal Dispute
28th Dec 20224:40 pmRNSSecond Price Monitoring Extn
28th Dec 20224:35 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.